We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
Medical Properties (MPW - Free Report) closed at $4.36 in the latest trading session, marking a +1.16% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.11%. At the same time, the Dow added 0.91%, and the tech-heavy Nasdaq lost 0.82%.
Shares of the health care real estate investment trust witnessed a loss of 3.79% over the previous month, trailing the performance of the Finance sector with its gain of 3.03%, and the S&P 500's gain of 5.17%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. The company is expected to report EPS of $0.13, down 43.48% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $231.15 million, indicating a 13.29% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.57 per share and revenue of $930.43 million. These totals would mark changes of -28.75% and -6.54%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Medical Properties is currently sporting a Zacks Rank of #2 (Buy).
Digging into valuation, Medical Properties currently has a Forward P/E ratio of 7.61. This expresses a discount compared to the average Forward P/E of 11.47 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 96, which puts it in the top 39% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
Medical Properties (MPW - Free Report) closed at $4.36 in the latest trading session, marking a +1.16% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.11%. At the same time, the Dow added 0.91%, and the tech-heavy Nasdaq lost 0.82%.
Shares of the health care real estate investment trust witnessed a loss of 3.79% over the previous month, trailing the performance of the Finance sector with its gain of 3.03%, and the S&P 500's gain of 5.17%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. The company is expected to report EPS of $0.13, down 43.48% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $231.15 million, indicating a 13.29% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.57 per share and revenue of $930.43 million. These totals would mark changes of -28.75% and -6.54%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Medical Properties is currently sporting a Zacks Rank of #2 (Buy).
Digging into valuation, Medical Properties currently has a Forward P/E ratio of 7.61. This expresses a discount compared to the average Forward P/E of 11.47 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 96, which puts it in the top 39% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.